Today’s cannabis news landscape is dominated by the spreading ripple effects of US federal rescheduling, with reform conversations gathering pace on both sides of the Atlantic. From Richard Branson’s renewed call for UK reform to a surprise pivot in Indiana and fresh evidence of public backing for federal change, the political mood music is shifting — and capital markets are starting to listen.
Sir Richard Branson has used the platform of rising public approval to press the UK government for cannabis policy reform, arguing that current laws are out of step with both medical evidence and the public mood. The intervention adds high-profile commercial weight to a debate that has been simmering for months, and lands at a moment when ministers can no longer dismiss reform as a fringe concern.
Source: Forbes
Indiana Governor Mike Braun has indicated he is open to considering marijuana legalisation after an external report set out the policy choices facing the state, marking a notable shift in a traditionally conservative jurisdiction. With Hoosiers reportedly spending close to $2 billion a year on cannabis purchased across state lines, the economic case for keeping that revenue at home is becoming increasingly difficult to ignore.
Source: Indiana Capital Chronicle
Fresh industry guidance has been released to help medical cannabis patients navigate the patchwork of international regulations governing travel with prescribed products. The document arrives as patient numbers continue to climb across the UK and Europe, and addresses one of the most persistent practical headaches that legal access has not yet resolved for the people who depend on it.
Source: Cannabis Health News
Legal analysts have set out the case that US federal rescheduling will progressively unlock banking and capital markets access for the cannabis industry, removing one of the sector’s most damaging structural drags. While the change does not deliver SAFE Banking-style protections overnight, it begins to dismantle the institutional rationale for keeping cannabis operators at arm’s length from mainstream finance.
Source: The National Law Review
A new study has confirmed that a clear majority of Americans support the federal rescheduling of cannabis, providing fresh political cover for an administration that has so far moved cautiously on the issue. The finding strengthens the case for further reform steps and underlines just how far public sentiment has moved ahead of federal policy in the United States.
Source: Medical Xpress
The connecting thread across today’s stories is momentum: public support, political openness and capital market readiness are converging in ways that make further cannabis policy reform feel less like a question of if and more like one of when. Watch the UK debate next, where Branson’s intervention may prove a tipping point.
Stay up to date with all the latest on the Cannabis News Hub.
The post Cannabis News Today — Thursday 30 April 2026: Branson Backs UK Reform as Indiana Reconsiders Legalisation appeared first on Business of Cannabis.
Continue reading...
Richard Branson Calls For UK Cannabis Reform As Public Support Grows
Sir Richard Branson has used the platform of rising public approval to press the UK government for cannabis policy reform, arguing that current laws are out of step with both medical evidence and the public mood. The intervention adds high-profile commercial weight to a debate that has been simmering for months, and lands at a moment when ministers can no longer dismiss reform as a fringe concern.
Source: Forbes
Indiana Governor Signals Openness to Marijuana Legalisation
Indiana Governor Mike Braun has indicated he is open to considering marijuana legalisation after an external report set out the policy choices facing the state, marking a notable shift in a traditionally conservative jurisdiction. With Hoosiers reportedly spending close to $2 billion a year on cannabis purchased across state lines, the economic case for keeping that revenue at home is becoming increasingly difficult to ignore.
Source: Indiana Capital Chronicle
Industry Publishes New Guidance for Patients Travelling with Medical Cannabis
Fresh industry guidance has been released to help medical cannabis patients navigate the patchwork of international regulations governing travel with prescribed products. The document arrives as patient numbers continue to climb across the UK and Europe, and addresses one of the most persistent practical headaches that legal access has not yet resolved for the people who depend on it.
Source: Cannabis Health News
Banking and Capital Markets Access Set To Expand With Rescheduling
Legal analysts have set out the case that US federal rescheduling will progressively unlock banking and capital markets access for the cannabis industry, removing one of the sector’s most damaging structural drags. While the change does not deliver SAFE Banking-style protections overnight, it begins to dismantle the institutional rationale for keeping cannabis operators at arm’s length from mainstream finance.
Source: The National Law Review
Majority of Americans Now Back Cannabis Rescheduling, Study Finds
A new study has confirmed that a clear majority of Americans support the federal rescheduling of cannabis, providing fresh political cover for an administration that has so far moved cautiously on the issue. The finding strengthens the case for further reform steps and underlines just how far public sentiment has moved ahead of federal policy in the United States.
Source: Medical Xpress
The connecting thread across today’s stories is momentum: public support, political openness and capital market readiness are converging in ways that make further cannabis policy reform feel less like a question of if and more like one of when. Watch the UK debate next, where Branson’s intervention may prove a tipping point.
Stay up to date with all the latest on the Cannabis News Hub.
The post Cannabis News Today — Thursday 30 April 2026: Branson Backs UK Reform as Indiana Reconsiders Legalisation appeared first on Business of Cannabis.
Continue reading...
